Lolly
03-14-2007, 06:26 PM
Breast Cancer Update: Conversations With Oncology Investigators
http://www.breastcancerupdate.com/clinicaltrials/2006/1/metastatic.asp
Scroll down to #18:
Does lapatinib improve outcomes when combined with trastuzumab in patients with HER2-positive metastatic disease?
<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com /><o:lock aspectratio=</o:lock><?xml:namespace prefix = v ns = "urn:schemas-microsoft-com:vml" /><v:shape id=_x0000_i1025 style="WIDTH: 405pt; HEIGHT: 54pt" alt="Title 18" type="#_x0000_t75"><v:imagedata src="file:///C:\DOCUME~1\FRANKG~1\LOCALS~1\Temp\msohtml1\01\cli p_image001.gif" o:href="http://www.breastcancerupdate.com/clinicaltrials/2006/1/images/title18.gif"></v:imagedata></v:shape>
http://www.breastcancerupdate.com/clinicaltrials/2006/1/metastatic.asp
Scroll down to #18:
Does lapatinib improve outcomes when combined with trastuzumab in patients with HER2-positive metastatic disease?
<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com /><o:lock aspectratio=</o:lock><?xml:namespace prefix = v ns = "urn:schemas-microsoft-com:vml" /><v:shape id=_x0000_i1025 style="WIDTH: 405pt; HEIGHT: 54pt" alt="Title 18" type="#_x0000_t75"><v:imagedata src="file:///C:\DOCUME~1\FRANKG~1\LOCALS~1\Temp\msohtml1\01\cli p_image001.gif" o:href="http://www.breastcancerupdate.com/clinicaltrials/2006/1/images/title18.gif"></v:imagedata></v:shape>